Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01198522
What this trial is testing

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection
Philogen S.p.A. 28
Early research (Phase 1)Ended earlyNCT00281996
What this trial is testing

Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Northwestern University 19
Not applicableActive Not RecruitingNCT03704662
What this trial is testing

Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Medical College of Wisconsin 102
Testing effectiveness (Phase 2)Looking for participantsNCT07306273
What this trial is testing

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00651742
What this trial is testing

Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
Taiho Oncology, Inc. 28
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Early research (Phase 1)Not Yet RecruitingNCT07608627
What this trial is testing

64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
City of Hope Medical Center 15
Very early researchEnded earlyNCT03600623
What this trial is testing

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerBorderline Pancreatic Inoperable CancerPancreatic Cancer
University of Alabama at Birmingham 25
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT02106884
What this trial is testing

Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel

Who this might be right for
Pancreatic Cancer
Universitaire Ziekenhuizen KU Leuven 146
Early research (Phase 1)Study completedNCT02045589
What this trial is testing

A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
Theriva Biologics SL 8
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Early research (Phase 1)Study completedNCT02394535
What this trial is testing

Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+4 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00429858
What this trial is testing

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Andrew Ko 21
Testing effectiveness (Phase 2)Study completedNCT02043730
What this trial is testing

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer Stage II
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente 124
Not applicableUnknownNCT04112836
What this trial is testing

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerExocrine Pancreatic InsufficiencyMetastatic Pancreatic Cancer+3 more
Moscow Clinical Scientific Center 186
Large-scale testing (Phase 3)Study completedNCT00040183
What this trial is testing

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
OSI Pharmaceuticals 569
Testing effectiveness (Phase 2)Active Not RecruitingNCT01585805
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Study completedNCT00350142
What this trial is testing

Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Albert Koong 20
Testing effectiveness (Phase 2)Study completedNCT03180437
What this trial is testing

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 62
Next Page